Coxsackie A2, A7, B1, B3, B5
Generic Name: coxsackie a2, a7, b1, b3, b5
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS A2 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS A7 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS B1 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS B3 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS B5 (7 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS A2 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS A7 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS B1 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS B3 (7 [hp_C]/mL); HUMAN COXSACKIEVIRUS B5 (7 [hp_C]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Strawberry Flavor Sodium Fluoride Anticavity Toothpaste
strawberry flavor sodium fluoride anticavity toothpaste
Purpose Anticavity
Paralithodes Camtschaticus, Crangon Crangon, Homarus Americanus, Crassostrea Virginica
paralithodes camtschaticus, crangon crangon, homarus americanus, crassostrea virginica
Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: AMERICAN LOBSTER (.1 g/mL); COMMON SHRIMP (.1 g/mL); EASTERN OYSTER (.1 g/mL); RED KING CRAB (.1 g/mL). Category: BLA.
Acetohydroxamic Acid
acetohydroxamic acid
Urease Inhibitor [EPC]
DESCRIPTION Acetohydroxamic acid (AHA) is a stable, synthetic compound derived from hydroxylamine and ethyl acetate. Its molecular structure is similar to urea: AHA is weakly acidic, highly soluble in water, and chelates metals - notably iron. The molecular weight is 75.068. AHA has a pKa of 9.32 and a melting point of 89-91° C. AHA is a urease inhibitor. Available as 250 mg tablets. Acetohydroxamic acid struct
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.